JP2003519676A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519676A5
JP2003519676A5 JP2001551838A JP2001551838A JP2003519676A5 JP 2003519676 A5 JP2003519676 A5 JP 2003519676A5 JP 2001551838 A JP2001551838 A JP 2001551838A JP 2001551838 A JP2001551838 A JP 2001551838A JP 2003519676 A5 JP2003519676 A5 JP 2003519676A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
unsubstituted
heteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001551838A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519676A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/001219 external-priority patent/WO2001051456A2/en
Publication of JP2003519676A publication Critical patent/JP2003519676A/ja
Publication of JP2003519676A5 publication Critical patent/JP2003519676A5/ja
Pending legal-status Critical Current

Links

JP2001551838A 2000-01-13 2001-01-12 抗菌剤 Pending JP2003519676A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17589200P 2000-01-13 2000-01-13
US60/175,892 2000-01-13
PCT/US2001/001219 WO2001051456A2 (en) 2000-01-13 2001-01-12 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2003519676A JP2003519676A (ja) 2003-06-24
JP2003519676A5 true JP2003519676A5 (enExample) 2008-02-07

Family

ID=22642090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001551838A Pending JP2003519676A (ja) 2000-01-13 2001-01-12 抗菌剤

Country Status (9)

Country Link
US (3) US6780858B2 (enExample)
EP (1) EP1246795B1 (enExample)
JP (1) JP2003519676A (enExample)
AT (1) ATE376996T1 (enExample)
AU (1) AU2001239725A1 (enExample)
CA (1) CA2397575A1 (enExample)
DE (1) DE60131138T2 (enExample)
ES (1) ES2293980T3 (enExample)
WO (1) WO2001051456A2 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376996T1 (de) 2000-01-13 2007-11-15 Amgen Inc Antibakterielle mittel
EP1372551B1 (en) 2001-03-08 2008-09-17 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers as anti-infective agents
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2003039529A1 (en) * 2001-11-07 2003-05-15 4Sc A.G. Selective antibacterial agents
US7338969B2 (en) 2002-03-08 2008-03-04 Quonova, Llc Modulation of pathogenicity
US7335779B2 (en) 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
AU2003236500B9 (en) 2002-06-12 2009-07-02 Chemocentryx, Inc. 1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
ATE402700T1 (de) * 2002-08-27 2008-08-15 Merck Patent Gmbh Glycinamid-derivate als raf-kinase-hemmer
MXPA05004206A (es) * 2002-10-24 2005-06-08 Merck Patent Gmbh Derivados de metilenurea.
US7078419B2 (en) 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
WO2004082634A2 (en) 2003-03-17 2004-09-30 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
WO2004089901A2 (en) * 2003-03-31 2004-10-21 Janssen Pharmaceutica N.V. Phospholipase c inhibitors for use in treating inflammatory disorders
EP1663204B1 (en) * 2003-08-29 2014-05-07 Exelixis, Inc. C-kit modulators and methods of use
EP1669348A4 (en) 2003-09-30 2009-03-11 Eisai R&D Man Co Ltd NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
JP4667384B2 (ja) 2003-10-07 2011-04-13 レノビス， インコーポレイテッド イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
CA2554163A1 (en) 2004-01-23 2005-08-11 The Trustees Of The University Of Pennsylvania Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
US7371743B2 (en) 2004-02-28 2008-05-13 Boehringer Ingelheim International Gmbh Carboxylic acid amides, the preparation thereof and their use as medicaments
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7250413B2 (en) 2004-04-26 2007-07-31 Cumbre Pharmaceuticals Inc. C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
WO2006040056A1 (en) * 2004-10-13 2006-04-20 Merck Patent Gmbh Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
WO2006082030A1 (en) * 2005-02-04 2006-08-10 Ctg Pharma S.R.L. New 4-aminoquinoline derivatives as antimalarials
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
JP4874958B2 (ja) 2005-03-30 2012-02-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピリジン誘導体を含有する抗真菌剤
DK2559690T3 (en) 2005-05-10 2016-04-25 Incyte Holdings Corp Modulators of indoleamine 2,3-dioxygenase and methods of use thereof
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
WO2007068394A2 (en) * 2005-12-13 2007-06-21 Arpida Ag Diphenyl urea derivatives
ES2540561T3 (es) * 2005-12-20 2015-07-10 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
ATE555091T1 (de) 2006-02-03 2012-05-15 Bionomics Ltd Substituierte benzofurane, benzothiophene, benzoselenophene und indole und ihre verwendung als tubulinpolymerisationsinhibitoren
WO2007095050A2 (en) * 2006-02-09 2007-08-23 Incyte Corporation N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
WO2007100657A2 (en) 2006-02-28 2007-09-07 Merck & Co., Inc. Inhibitors of histone deacetylase
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
WO2008036652A2 (en) * 2006-09-19 2008-03-27 Incyte Corporation Amidines as modulators of indoleamine 2,3-dioxygenase
US20080125470A1 (en) * 2006-09-19 2008-05-29 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20080182882A1 (en) * 2006-11-08 2008-07-31 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
EP2124562B1 (en) 2007-03-09 2016-04-20 Second Genome, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
GB0718735D0 (en) * 2007-09-25 2007-11-07 Prolysis Ltd Antibacterial agents
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
GB2461167B (en) * 2008-06-24 2012-12-26 Scynexis Inc Novel amidoxime derivatives
NZ590268A (en) 2008-07-08 2012-11-30 Incyte Corp 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
US20110237679A1 (en) * 2008-12-09 2011-09-29 Cytokine Pharmasciences, Inc. Novel antiviral compounds, compositions, and methods of use
WO2010123591A2 (en) * 2009-01-09 2010-10-28 The Uab Research Foundation Small molecule inhibitors of nads, namnat, and nmnat
EP2385829B1 (en) * 2009-01-09 2018-08-01 Board of Regents of the University of Texas System Pro-neurogenic compounds
US9162980B2 (en) 2009-01-09 2015-10-20 Board Of Regents Of The University Of Texas System Anti-depression compounds
US9962368B2 (en) 2009-01-09 2018-05-08 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
US8362277B2 (en) 2009-01-09 2013-01-29 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
AU2010243353B2 (en) 2009-04-30 2014-09-11 Astex Therapeutics Limited Imidazole derivatives and their use as modulators of Cyclin dependent Kinases
CN103415289B (zh) 2010-07-07 2017-04-12 得克萨斯州大学系统董事会 前神经原性化合物
WO2013106409A1 (en) * 2012-01-10 2013-07-18 Merck Patent Gmbh Benzamide derivatives as modulators of the follicle stimulating hormone
WO2014031986A1 (en) 2012-08-24 2014-02-27 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
BR112015011253B1 (pt) * 2012-11-21 2021-11-09 Nippon Soda Co., Ltd Material de gravação, folha de gravação, método para uso de um composto
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
JP6423372B2 (ja) 2013-02-28 2018-11-14 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 強力なｒｏｃｋ１およびｒｏｃｋ２阻害剤としてのフェニルピラゾール誘導体
CR20160252A (es) 2013-11-08 2016-09-19 Incyte Holdings Corp Proceso para la sintesis de un inhibidor de indolamina 2,3-dioxigenasa
EP3068388A4 (en) 2013-11-11 2017-04-12 Board of Regents of the University of Texas System Neuroprotective compounds and use thereof
WO2015070237A1 (en) 2013-11-11 2015-05-14 Board Of Regents Of The University Of Texas System Neuroprotective chemicals and methods for identifying and using same
CN104725276B (zh) * 2013-12-18 2017-05-10 浙江省化工研究院有限公司 一种含七氟异丙基的羰基肟醚类化合物、其制备方法及应用
WO2022166741A1 (zh) * 2021-02-06 2022-08-11 正大天晴药业集团股份有限公司 含有苯并杂环的作为egfr激酶抑制剂的大环化合物、其药物组合物和用途
CR20230576A (es) 2021-06-14 2024-04-05 Scorpion Therapeutics Inc Derivados de la urea que pueden ser utilizados para tratar el cáncer
CN113754564B (zh) * 2021-08-02 2022-08-26 湖南大学 具有抗耐药性的抗菌脒类低聚物及其制作方法和用途
EP4660184A1 (en) * 2023-01-30 2025-12-10 Eurofarma Laboratórios S.A. Nav1.7- and/or nav1.8-inhibiting hydroxamates, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
AR131715A1 (es) * 2023-01-30 2025-04-23 Eurofarma Laboratorios S A AMIDAS BLOQUEADORAS DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y KITS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3347874A (en) * 1963-01-09 1967-10-17 Union Carbide Corp 5-nitrofuryl-2-amidoximes
JPS49124204A (enExample) * 1973-04-02 1974-11-28
DE2623228C3 (de) * 1976-05-24 1981-09-10 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
DE2801509A1 (de) 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
JPS6434954A (en) * 1987-02-18 1989-02-06 Hokko Chem Ind Co Benzenecarboximidamide derivative and agricultural and horticultural fungicide
JPS63316703A (ja) * 1987-06-19 1988-12-26 Hokko Chem Ind Co Ltd 薬害軽減作用を有する農園芸用殺菌・除草剤
JPS6413071A (en) * 1987-07-07 1989-01-17 Fuji Photo Film Co Ltd Production of 3-alkoxy-5-amino-1h-pyrazoles
JPH01215994A (ja) * 1988-02-24 1989-08-29 Hokko Chem Ind Co Ltd 電解反応によるベンゼンカルボキシイミダミド誘導体の製造方法
JPH07122744B2 (ja) * 1988-12-15 1995-12-25 富士写真フイルム株式会社 マゼンタ色素形成カプラーおよびカラー画像形成方法
JPH02201358A (ja) * 1989-01-30 1990-08-09 Konica Corp 新規なシアンカプラーを含有するハロゲン化銀カラー写真感光材料
JPH03148267A (ja) * 1989-11-01 1991-06-25 Hokko Chem Ind Co Ltd １，２，４―オキサジアジン―５―オン誘導体および農園芸用殺菌剤
JPH1171336A (ja) * 1997-06-25 1999-03-16 Mitsubishi Chem Corp アミド誘導体
US7653495B1 (en) * 1998-07-01 2010-01-26 The Trustees Of The University Of Pennsylvania Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
NZ510588A (en) * 1998-09-18 2003-08-29 Abbott Gmbh & Co Pyrrolopyrimidines as protein kinase inhibitors
WO2000037434A1 (en) * 1998-12-22 2000-06-29 Mitsubishi Chemical Corporation Amide derivatives
ATE376996T1 (de) * 2000-01-13 2007-11-15 Amgen Inc Antibakterielle mittel

Similar Documents

Publication Publication Date Title
JP2003519676A5 (enExample)
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2002541233A5 (enExample)
JP2005526857A5 (enExample)
JP2002536445A5 (enExample)
JP2001519410A5 (enExample)
JP2002513668A5 (enExample)
RU2001104339A (ru) Производные тиобензимидазола
JP2002536329A5 (enExample)
JP2006501181A5 (enExample)
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
JP2002502874A5 (enExample)
JP2006511484A5 (enExample)
JP2002527434A5 (enExample)
JP2002508352A5 (ja) ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体）
JP2010530881A5 (enExample)
JP2004533444A5 (enExample)
JP2001525394A5 (enExample)
JP2007246474A5 (enExample)
JP2002527414A5 (enExample)
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2002521334A5 (enExample)
JP2003502367A5 (enExample)
JP2009520695A5 (enExample)
KR920002588A (ko) 신규 3-아릴인돌 및 3-아릴인다졸 유도체